Haibo Yu

机构：Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Heilongjiang Provincial Hospital · ORCID：0000-0002-1744-990X

发表论文 84 篇 · 总被引 1484 次 · h-index 21

代表论文

• Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain (2023 · Acta Pharmaceutica Sinica B · 被引 28)
• Design, synthesis, anticonvulsant activity and structure-activity relationships of novel 7-Azaindole derivatives (2023 · Bioorganic Chemistry · 被引 13)
• Design, synthesis and structure-activity relationship of novel 1,2,4-triazolopyrimidin-5-one derivatives targeting GABAA1 and Nav1.2 with antiepileptic activity (2025 · European Journal of Medicinal Chemistry · 被引 11)
• Schisandrin B, a dual positive allosteric modulator of GABAA and glycine receptors, alleviates seizures in multiple mouse models (2023 · Acta Pharmacologica Sinica · 被引 11)
• SQOR as a metabolic rheostat of H2S: structure, redox homeostasis, and disease therapy (2025 · Frontiers in Cell and Developmental Biology · 被引 7)
• Lactobacillus rhamnosus B16 regulates lipid metabolism homeostasis by producing acetic acid (2025 · Journal of Translational Medicine · 被引 7)